Hillard, C J <br/><br/>
Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619.  [electronic resource] 

 -  British journal of pharmacology  Nov 2007 
 - 691-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0007-1188 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjp.0707468  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid--pharmacology<br/>Amidohydrolases--antagonists & inhibitors<br/>Aniline Compounds--pharmacology<br/>Animals<br/>Arachidonic Acid--metabolism<br/>Arachidonic Acids--metabolism<br/>Benzamides--pharmacology<br/>Benzoxazines--pharmacology<br/>Carbamates--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Endocannabinoids<br/>Enzyme Inhibitors--pharmacology<br/>Glycerides--metabolism<br/>In Vitro Techniques<br/>Male<br/>Middle Cerebral Artery--drug effects<br/>Morpholines--pharmacology<br/>Naphthalenes--pharmacology<br/>Nimodipine--pharmacology<br/>Piperidines--pharmacology<br/>Pyrazoles--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor, Cannabinoid, CB1--antagonists & inhibitors<br/>Rimonabant<br/>Thromboxanes--pharmacology<br/>Vasoconstriction--drug effects<br/>Vasoconstrictor Agents--pharmacology